These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32007583)
1. Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations. Al-Eitan LN Gene; 2020 May; 737():144408. PubMed ID: 32007583 [TBL] [Abstract][Full Text] [Related]
2. Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan. Al-Eitan LN; Al-Maqableh HW; Mohammad NN; Hakooz NM; Dajani RB Curr Drug Metab; 2020; 21(4):307-317. PubMed ID: 32368972 [TBL] [Abstract][Full Text] [Related]
3. Genetic Polymorphisms of Pharmacogenomic VIP Variants in the Circassian Subpopulation from Jordan. Al-Eitan LN; Mohammad NN; Al-Maqableh HW; Hakooz NM; Dajani RB Curr Drug Metab; 2019; 20(8):674-681. PubMed ID: 31362667 [TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China. He Y; Yang H; Geng T; Feng T; Yuan D; Kang L; Luo M; Jin T Int J Clin Exp Pathol; 2015; 8(10):13293-303. PubMed ID: 26722533 [TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China. Zhang C; Guo W; Cheng Y; Li Q; Yang X; Dai R; Zhu L; Chen W Mol Genet Genomic Med; 2019 May; 7(5):e574. PubMed ID: 30955239 [TBL] [Abstract][Full Text] [Related]
6. Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China. Wang Y; Peng L; Lu H; Zhang Z; Xing S; Li D; He C; Jin T; Wang L Pharmgenomics Pers Med; 2021; 14():1647-1660. PubMed ID: 34949935 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China. Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Comprehensive Pharmacogenomic Profiling of VIP Variants Among the Genetically Isolated Chechen Subpopulation from Jordan. Al-Eitan LN; Rababa'h DM; Hakooz NM; Alghamdi MA; Dajani RB Pharmgenomics Pers Med; 2020; 13():199-215. PubMed ID: 32765042 [TBL] [Abstract][Full Text] [Related]
9. Variability of CYP2C8 Polymorphisms in Three Jordanian Populations: Circassians, Chechens and Jordanian-Arabs. Abudahab S; Hakooz N; Tobeh N; Gogazeh E; Gharaibeh M; Al-Eitan L; Zihlif M; Dajani R J Immigr Minor Health; 2022 Oct; 24(5):1167-1176. PubMed ID: 34448113 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations. Jmel H; Romdhane L; Ben Halima Y; Hechmi M; Naouali C; Dallali H; Hamdi Y; Shan J; Abid A; Jamoussi H; Trabelsi S; Chouchane L; Luiselli D; Abdelhak S; Kefi R PLoS One; 2018; 13(4):e0194842. PubMed ID: 29652911 [TBL] [Abstract][Full Text] [Related]
11. Characterization of serotonin transporter gene (SLC6A4) polymorphisms and its association with drug dependence in a Jordanian Arab population. Al-Eitan LN; Jaradat SA; Qin W; Wildenauer DM; Wildenauer DD; Hulse GK; Tay GK Toxicol Ind Health; 2014 Aug; 30(7):598-610. PubMed ID: 23033208 [TBL] [Abstract][Full Text] [Related]
12. Analysis of very important pharmacogene variants in the Tibetan population from China. Rong H; Dong H; He X; Yuan D; Bai M; Wang L; Liu T; He Y; Zheng J; Wang Y; Jin T Clin Exp Pharmacol Physiol; 2021 May; 48(5):668-678. PubMed ID: 32311112 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province. Cheng Y; Dai R; Chen W; Li Q; Zhang C; Yang T Mol Genet Genomic Med; 2020 Jul; 8(7):e1231. PubMed ID: 32347657 [TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population. Jin TB; Xun XJ; Shi XG; Yuan DY; Feng T; Geng TT; Kang LL Genet Mol Res; 2015 Oct; 14(4):12497-504. PubMed ID: 26505400 [TBL] [Abstract][Full Text] [Related]
15. Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study. Al-Eitan LN; Jamous RI; Khasawneh RH Cancer Invest; 2017 Apr; 35(4):256-270. PubMed ID: 28272917 [TBL] [Abstract][Full Text] [Related]
16. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations. Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251 [TBL] [Abstract][Full Text] [Related]
17. Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan. Al-Eitan LN; Rababa'h DM; Hakooz NM; Alghamdi MA; Dajani RB J Pers Med; 2020 Jan; 10(1):. PubMed ID: 31935801 [TBL] [Abstract][Full Text] [Related]
18. Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. Al-Eitan LN; Jaradat SA; Hulse GK; Tay GK BMC Res Notes; 2012 Sep; 5():497. PubMed ID: 22963930 [TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province. Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T Gene; 2022 Nov; 844():146825. PubMed ID: 35995116 [TBL] [Abstract][Full Text] [Related]
20. The Nudix Hydrolase 15 (NUDT15) Gene Variants among Jordanian Arab Population. Jarrar YB; Ghishan M Asian Pac J Cancer Prev; 2019 Mar; 20(3):801-808. PubMed ID: 30909691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]